DE60216641D1 - Polymorph von 4-ä2-ä4-ä1-(2-ethoxyethyl)-1h-benzimidazol-2-ylü-1-piperidinylüethylü-alpha, alpha-dimethylbenzolessigsäure - Google Patents

Polymorph von 4-ä2-ä4-ä1-(2-ethoxyethyl)-1h-benzimidazol-2-ylü-1-piperidinylüethylü-alpha, alpha-dimethylbenzolessigsäure

Info

Publication number
DE60216641D1
DE60216641D1 DE60216641T DE60216641T DE60216641D1 DE 60216641 D1 DE60216641 D1 DE 60216641D1 DE 60216641 T DE60216641 T DE 60216641T DE 60216641 T DE60216641 T DE 60216641T DE 60216641 D1 DE60216641 D1 DE 60216641D1
Authority
DE
Germany
Prior art keywords
alpha
ylü
piperidinylüethylü
dimethylbenzolic
polymorph
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60216641T
Other languages
English (en)
Other versions
DE60216641T2 (de
Inventor
Venero Aurelio Orjales
Martin Maravillas Bordell
Mori Gonzalo Canal
Fuente Haydee Blanco
De Pablo Maria Luisa Lucero
Royo Victor Rubio
Pestana Ramon Mosquera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Faes Farma SA
Original Assignee
Faes Farma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29225789&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60216641(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Faes Farma SA filed Critical Faes Farma SA
Publication of DE60216641D1 publication Critical patent/DE60216641D1/de
Application granted granted Critical
Publication of DE60216641T2 publication Critical patent/DE60216641T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60216641T 2002-04-19 2002-04-19 Polymorph von 4-ä2-ä4-ä1-(2-ethoxyethyl)-1h-benzimidazol-2-ylü-1-piperidinylüethylü-alpha, alpha-dimethylbenzolessigsäure Expired - Lifetime DE60216641T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2002/000194 WO2003089425A1 (es) 2002-04-19 2002-04-19 POLIMORFO DEL ÁCIDO 4-[2-[4-[1-(2-ETOXIETIL)-1H-BENCIMIDAZOL-2-IL]-1-PIPERIDINIL]ETIL]-α, α-DIMETIL-BENCENOACÉTICO

Publications (2)

Publication Number Publication Date
DE60216641D1 true DE60216641D1 (de) 2007-01-18
DE60216641T2 DE60216641T2 (de) 2007-09-27

Family

ID=29225789

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60216641T Expired - Lifetime DE60216641T2 (de) 2002-04-19 2002-04-19 Polymorph von 4-ä2-ä4-ä1-(2-ethoxyethyl)-1h-benzimidazol-2-ylü-1-piperidinylüethylü-alpha, alpha-dimethylbenzolessigsäure

Country Status (31)

Country Link
US (2) US7612095B2 (de)
EP (1) EP1505066B1 (de)
JP (1) JP5142448B2 (de)
KR (1) KR100673140B1 (de)
CN (1) CN1290843C (de)
AR (1) AR039423A1 (de)
AT (1) ATE347550T1 (de)
AU (1) AU2002255017B2 (de)
BG (1) BG66302B1 (de)
BR (1) BRPI0215703B8 (de)
CA (1) CA2484460C (de)
CY (2) CY1107564T1 (de)
CZ (1) CZ305162B6 (de)
DE (1) DE60216641T2 (de)
DK (1) DK1505066T3 (de)
ES (1) ES2278018T3 (de)
HK (1) HK1072772A1 (de)
HR (1) HRP20041048B1 (de)
HU (1) HU230032B1 (de)
IL (1) IL164645A (de)
MX (1) MXPA04010313A (de)
NO (1) NO329327B1 (de)
NZ (1) NZ536551A (de)
PA (1) PA8571201A1 (de)
PE (1) PE20040086A1 (de)
PT (1) PT1505066E (de)
SI (1) SI1505066T1 (de)
SK (1) SK288052B6 (de)
UA (1) UA76866C2 (de)
UY (1) UY27762A1 (de)
WO (1) WO2003089425A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa ４−［２−［１−（２−エトキシエチル）−１Ｈ−ベンズイミダゾール−２−イル］−１−ピペリジニル］エチル］−α，α−ジメチルベンゼノ酢酸の多形体
WO2013001731A1 (ja) * 2011-06-30 2013-01-03 パナソニック株式会社 通信システム、ユーザ端末並びに通信装置
CN102675101B (zh) * 2012-05-16 2014-01-29 王蕾 2-(4-卤乙基)苯基-2-甲基丙酸酯的制备方法及合成比拉斯汀的方法
CZ307500B6 (cs) 2012-08-15 2018-10-24 Zentiva, K.S. Způsob přípravy derivátu 2-methyl-2´-fenylpropionové kyseliny využívající nové intermediáty
CN103214454A (zh) * 2013-03-30 2013-07-24 北京万全德众医药生物技术有限公司 一种比拉斯汀晶型及制备方法
WO2014188453A2 (en) * 2013-05-24 2014-11-27 Msn Laboratories Private Limited Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid
CN103356616A (zh) * 2013-06-29 2013-10-23 北京万全德众医药生物技术有限公司 一种含有比拉斯汀的药物组合物及其制备方法
CN104447682A (zh) * 2013-09-12 2015-03-25 天津市汉康医药生物技术有限公司 比拉斯汀化合物
CN104398481A (zh) * 2014-10-29 2015-03-11 万全万特制药江苏有限公司 比拉斯汀口崩片及其制备方法
CA2993134A1 (en) * 2015-07-24 2017-02-02 Urquima, S.A. Crystalline forms of bilastine and preparation methods thereof
EP3170817A1 (de) 2015-11-20 2017-05-24 Faes Farma, S.A. Cokristalle von benzimidazolverbindungen
EP3170816A1 (de) * 2015-11-20 2017-05-24 Faes Farma, S.A. Übersättigte zusammensetzungen von benzimidazolverbindungen
WO2017167949A1 (en) 2016-04-01 2017-10-05 Krka, D.D., Novo Mesto Crystalline forms of bilastine
WO2017191651A1 (en) * 2016-05-05 2017-11-09 Msn Laboratories Private Limited, R & D Center Solid state forms of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl)phenyl]-2-methylpropanoic acid and process for preparation thereof
EP3453384B1 (de) 2017-09-07 2020-05-27 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmazeutische tablette enhaltend bilastin
EP3641735B1 (de) * 2017-12-18 2021-02-24 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmazeutische tablettenzusammensetzung mit bilastinform 3 und wasserlöslichem füllstoff
EP3470062B1 (de) 2017-12-18 2020-10-28 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmazeutische tablettenzusammensetzung mit bilastin polymorph form 3 und magnesiumaluminometasilikat
WO2019141563A1 (en) 2018-01-18 2019-07-25 Faes Farma, S.A. Ophthalmic compositions comprising bilastine, a beta-cyclodextrin and at least one gelling agent
CA3200779A1 (en) 2020-12-23 2022-06-30 Strusi ORAZIO LUCA A non-micronized bilastine composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810789A (en) * 1987-08-28 1989-03-07 Bristol-Myers Company Process for buspirone hydrochloride polymorphic crystalline form conversion
ES2124167B1 (es) * 1996-06-04 1999-09-16 Espanola Prod Quimicos Nuevos derivados del bencimidazol con actividad antihistaminica.
BR0010683A (pt) * 1999-04-16 2003-07-01 Reddy Research Foundation Formas polimórficas de um agente antidiabético: processo para seu preparo e composições farmacêuticas contendo o mesmo
CO5170421A1 (es) * 1999-04-23 2002-06-27 Smithkline Beecham Plc Nuevo compuesto farmaceutico maleico

Also Published As

Publication number Publication date
UY27762A1 (es) 2003-09-30
IL164645A0 (en) 2005-12-18
EP1505066A1 (de) 2005-02-09
BRPI0215703B8 (pt) 2021-05-25
PA8571201A1 (es) 2003-12-10
BRPI0215703B1 (pt) 2017-06-27
NO20044999L (no) 2005-01-14
CY2013015I2 (el) 2015-08-05
ATE347550T1 (de) 2006-12-15
CZ305162B6 (cs) 2015-05-27
CA2484460A1 (en) 2003-10-30
SK50202004A3 (sk) 2005-05-05
CY1107564T1 (el) 2013-03-13
PE20040086A1 (es) 2004-04-27
DK1505066T3 (da) 2007-03-19
BG108941A (en) 2005-12-30
KR20050005448A (ko) 2005-01-13
UA76866C2 (uk) 2006-09-15
SK288052B6 (sk) 2013-03-01
BG66302B1 (bg) 2013-03-29
US20050203141A1 (en) 2005-09-15
SI1505066T1 (sl) 2007-04-30
PT1505066E (pt) 2007-03-30
HRP20041048A9 (hr) 2013-01-31
MXPA04010313A (es) 2005-06-08
CY2013015I1 (el) 2015-08-05
HK1072772A1 (en) 2005-09-09
ES2278018T3 (es) 2007-08-01
HRP20041048B1 (hr) 2013-04-30
HU230032B1 (hu) 2015-05-28
IL164645A (en) 2010-11-30
AU2002255017A1 (en) 2003-11-03
JP2005529120A (ja) 2005-09-29
US7612095B2 (en) 2009-11-03
JP5142448B2 (ja) 2013-02-13
AR039423A1 (es) 2005-02-16
CN1628112A (zh) 2005-06-15
NO329327B1 (no) 2010-09-27
CN1290843C (zh) 2006-12-20
WO2003089425A1 (es) 2003-10-30
HUP0500241A2 (hu) 2005-06-28
BR0215703A (pt) 2005-02-01
CA2484460C (en) 2009-09-29
NZ536551A (en) 2006-08-31
KR100673140B1 (ko) 2007-01-22
HRP20041048A2 (en) 2005-02-28
US20100004285A1 (en) 2010-01-07
DE60216641T2 (de) 2007-09-27
AU2002255017B2 (en) 2008-11-13
EP1505066B1 (de) 2006-12-06
CZ20041122A3 (cs) 2005-03-16

Similar Documents

Publication Publication Date Title
DE60216641D1 (de) Polymorph von 4-ä2-ä4-ä1-(2-ethoxyethyl)-1h-benzimidazol-2-ylü-1-piperidinylüethylü-alpha, alpha-dimethylbenzolessigsäure
ATE517887T1 (de) Neue 2-pyridincarbonsäureamidderivate
ATE525377T1 (de) Imidazoä1,5-aüpyrazine als inhibitoren von tyrosinkinase
NO20055459D0 (no) Prosesser
DK1567112T3 (da) Thiazolidin-4-oner til at hæmme hYAK3-proteiner
ATE469878T1 (de) Aminobenzophenonverbindungen
NO20053753D0 (no) Karboksylsyreforbindelser.
DE602004006228D1 (de) Identifikation alternierender t-wellen
DK1666477T3 (da) 7-(4-trisubstitueret 3-cyclopropylaminomethyl-1- pyrrolidinyl)-quinoloncarboxylsyre-derivat
DE60217089D1 (de) Lipidsenkende biphenylcarbonsäureamide
DE602005010986D1 (de) Neue pyrrolidin-3,4-dicarbonsäureamidderivate
ATE384530T1 (de) 4-aminochinolin-3-carbonsäureamid-derivate als pde4-hemmer
NO20034955D0 (no) Korrosjonsinhibitor
DE50309027D1 (de) Geschäumte haftklebemassen
DE60324703D1 (de) Barbitursäure derivaten.
NO20053408D0 (no) Syklopropyl beta-aminosyrederivater.
IS7943A (is) Ný amínóbensófenónefnasambönd
DE602004031534D1 (de) Stabiler polymorph von bifeprunoxmesilat
ITRM20030416A1 (it) Procedimento per la purificazione di acidi solforici.
DE50308413D1 (de) Kontaktierung von nanoröhren
ATE394370T1 (de) Von vitamin d abgeleitete monohalogenvinylverbindungen
DE60331820D1 (de) Beseitigung von verstopfungen von rohrleitungen
NO20042664L (no) Karboksylsyrederivat
DE602005011673D1 (de) Ion von olefinen
ATE297382T1 (de) 3-heterocyclyl propanohydroxamsäure-derivaten als pcp inhibitoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition